 | • レポートコード：GIR201111782 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、ハーセプチンバイオシミラーの世界市場を調査対象にし、ハーセプチンバイオシミラーの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（乳がん、結腸直腸がん、白血病、リンパ腫、その他）、用途別分析（病院＆クリニック、腫瘍学センター、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Amgen、Mylan、Celltrion、AryoGen Biopharma、Mabion、Biocon、The Instituto Vital Brazil、Genor Biopharma、Gedeon Richter、Roche ・メーカー別販売量、売上、市場シェア ・ハーセプチンバイオシミラーの地域別市場分析 ・ハーセプチンバイオシミラーの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・ハーセプチンバイオシミラーのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・ハーセプチンバイオシミラーのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・ハーセプチンバイオシミラーの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・ハーセプチンバイオシミラーの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・ハーセプチンバイオシミラーの種類別市場規模2015-2020：乳がん、結腸直腸がん、白血病、リンパ腫、その他 ・ハーセプチンバイオシミラーの用途別市場規模2015-2020：病院＆クリニック、腫瘍学センター、その他 ・ハーセプチンバイオシミラーの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Herceptin Biosimilar market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Herceptin Biosimilar market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Herceptin Biosimilar market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Herceptin Biosimilar market has been segmented into
Breast Cancer
Colorectal Cancer
Leukemia
Lymphoma
Other
By Application, Herceptin Biosimilar has been segmented into:
Hospital & Clinics
Oncology Centers
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Herceptin Biosimilar market presented in the report. This section sheds light on the sales growth of different regional and country-level Herceptin Biosimilar markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Herceptin Biosimilar market.
The report offers in-depth assessment of the growth and other aspects of the Herceptin Biosimilar market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Herceptin Biosimilar Market Share Analysis
Herceptin Biosimilar competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Herceptin Biosimilar sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Herceptin Biosimilar sales, revenue and market share for each player covered in this report.
The major players covered in Herceptin Biosimilar are:
Amgen
Mylan
Celltrion
AryoGen Biopharma
Mabion
Biocon
The Instituto Vital Brazil
Genor Biopharma
Gedeon Richter
Roche
Among other players domestic and global, Herceptin Biosimilar market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Herceptin Biosimilar product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Herceptin Biosimilar, with price, sales, revenue and global market share of Herceptin Biosimilar in 2018 and 2019.
Chapter 3, the Herceptin Biosimilar competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Herceptin Biosimilar breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Herceptin Biosimilar market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Herceptin Biosimilar sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Herceptin Biosimilar Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Herceptin Biosimilar Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Breast Cancer
1.2.3 Colorectal Cancer
1.2.4 Leukemia
1.2.5 Lymphoma
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Herceptin Biosimilar Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital & Clinics
1.3.3 Oncology Centers
1.3.4 Other
1.4 Overview of Global Herceptin Biosimilar Market
1.4.1 Global Herceptin Biosimilar Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Amgen SWOT Analysis
2.1.4 Amgen Product and Services
2.1.5 Amgen Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Mylan
2.2.1 Mylan Details
2.2.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Mylan SWOT Analysis
2.2.4 Mylan Product and Services
2.2.5 Mylan Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Celltrion
2.3.1 Celltrion Details
2.3.2 Celltrion Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Celltrion SWOT Analysis
2.3.4 Celltrion Product and Services
2.3.5 Celltrion Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 AryoGen Biopharma
2.4.1 AryoGen Biopharma Details
2.4.2 AryoGen Biopharma Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AryoGen Biopharma SWOT Analysis
2.4.4 AryoGen Biopharma Product and Services
2.4.5 AryoGen Biopharma Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Mabion
2.5.1 Mabion Details
2.5.2 Mabion Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Mabion SWOT Analysis
2.5.4 Mabion Product and Services
2.5.5 Mabion Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Biocon
2.6.1 Biocon Details
2.6.2 Biocon Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Biocon SWOT Analysis
2.6.4 Biocon Product and Services
2.6.5 Biocon Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 The Instituto Vital Brazil
2.7.1 The Instituto Vital Brazil Details
2.7.2 The Instituto Vital Brazil Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 The Instituto Vital Brazil SWOT Analysis
2.7.4 The Instituto Vital Brazil Product and Services
2.7.5 The Instituto Vital Brazil Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Genor Biopharma
2.8.1 Genor Biopharma Details
2.8.2 Genor Biopharma Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Genor Biopharma SWOT Analysis
2.8.4 Genor Biopharma Product and Services
2.8.5 Genor Biopharma Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Gedeon Richter
2.9.1 Gedeon Richter Details
2.9.2 Gedeon Richter Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Gedeon Richter SWOT Analysis
2.9.4 Gedeon Richter Product and Services
2.9.5 Gedeon Richter Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Roche
2.10.1 Roche Details
2.10.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Roche SWOT Analysis
2.10.4 Roche Product and Services
2.10.5 Roche Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Herceptin Biosimilar Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Herceptin Biosimilar Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Herceptin Biosimilar Manufacturer Market Share in 2019
3.3.2 Top 6 Herceptin Biosimilar Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Herceptin Biosimilar Sales, Revenue and Market Share by Regions
4.1.1 Global Herceptin Biosimilar Sales and Market Share by Regions (2015-2020)
4.1.2 Global Herceptin Biosimilar Revenue and Market Share by Regions (2015-2020)
4.2 North America Herceptin Biosimilar Sales and Growth Rate (2015-2020)
4.3 Europe Herceptin Biosimilar Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Herceptin Biosimilar Sales and Growth Rate (2015-2020)
4.5 South America Herceptin Biosimilar Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Herceptin Biosimilar Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Herceptin Biosimilar Sales, Revenue and Market Share by Country
5.1.1 North America Herceptin Biosimilar Sales and Market Share by Country (2015-2020)
5.1.2 North America Herceptin Biosimilar Revenue and Market Share by Country (2015-2020)
5.2 United States Herceptin Biosimilar Sales and Growth Rate (2015-2020)
5.3 Canada Herceptin Biosimilar Sales and Growth Rate (2015-2020)
5.4 Mexico Herceptin Biosimilar Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Herceptin Biosimilar Sales, Revenue and Market Share by Country
6.1.1 Europe Herceptin Biosimilar Sales and Market Share by Country (2015-2020)
6.1.2 Europe Herceptin Biosimilar Revenue and Market Share by Country (2015-2020)
6.2 Germany Herceptin Biosimilar Sales and Growth Rate (2015-2020)
6.3 UK Herceptin Biosimilar Sales and Growth Rate (2015-2020)
6.4 France Herceptin Biosimilar Sales and Growth Rate (2015-2020)
6.5 Russia Herceptin Biosimilar Sales and Growth Rate (2015-2020)
6.6 Italy Herceptin Biosimilar Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Herceptin Biosimilar Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Herceptin Biosimilar Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Herceptin Biosimilar Revenue and Market Share by Regions (2015-2020)
7.2 China Herceptin Biosimilar Sales and Growth Rate (2015-2020)
7.3 Japan Herceptin Biosimilar Sales and Growth Rate (2015-2020)
7.4 Korea Herceptin Biosimilar Sales and Growth Rate (2015-2020)
7.5 India Herceptin Biosimilar Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Herceptin Biosimilar Sales and Growth Rate (2015-2020)
7.7 Australia Herceptin Biosimilar Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Herceptin Biosimilar Sales, Revenue and Market Share by Country
8.1.1 South America Herceptin Biosimilar Sales and Market Share by Country (2015-2020)
8.1.2 South America Herceptin Biosimilar Revenue and Market Share by Country (2015-2020)
8.2 Brazil Herceptin Biosimilar Sales and Growth Rate (2015-2020)
8.3 Argentina Herceptin Biosimilar Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Herceptin Biosimilar Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Herceptin Biosimilar Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Herceptin Biosimilar Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Herceptin Biosimilar Sales and Growth Rate (2015-2020)
9.3 Turkey Herceptin Biosimilar Sales and Growth Rate (2015-2020)
9.4 Egypt Herceptin Biosimilar Sales and Growth Rate (2015-2020)
9.5 South Africa Herceptin Biosimilar Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Herceptin Biosimilar Sales and Market Share by Type (2015-2020)
10.2 Global Herceptin Biosimilar Revenue and Market Share by Type (2015-2020)
10.3 Global Herceptin Biosimilar Price by Type (2015-2020)
11 Global Herceptin Biosimilar Market Segment by Application
11.1 Global Herceptin Biosimilar Sales Market Share by Application (2015-2020)
11.2 Global Herceptin Biosimilar Revenue Market Share by Application (2015-2020)
11.3 Global Herceptin Biosimilar Price by Application (2015-2020)
12 Market Forecast
12.1 Global Herceptin Biosimilar Sales, Revenue and Growth Rate (2021-2025)
12.2 Herceptin Biosimilar Market Forecast by Regions (2021-2025)
12.2.1 North America Herceptin Biosimilar Market Forecast (2021-2025)
12.2.2 Europe Herceptin Biosimilar Market Forecast (2021-2025)
12.2.3 Asia-Pacific Herceptin Biosimilar Market Forecast (2021-2025)
12.2.4 South America Herceptin Biosimilar Market Forecast (2021-2025)
12.2.5 Middle East & Africa Herceptin Biosimilar Market Forecast (2021-2025)
12.3 Herceptin Biosimilar Market Forecast by Type (2021-2025)
12.3.1 Global Herceptin Biosimilar Sales Forecast by Type (2021-2025)
12.3.2 Global Herceptin Biosimilar Market Share Forecast by Type (2021-2025)
12.4 Herceptin Biosimilar Market Forecast by Application (2021-2025)
12.4.1 Global Herceptin Biosimilar Sales Forecast by Application (2021-2025)
12.4.2 Global Herceptin Biosimilar Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Herceptin Biosimilar Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Herceptin Biosimilar by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Herceptin Biosimilar Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Amgen Basic Information, Manufacturing Base and Competitors
Table 8. Amgen Herceptin Biosimilar Major Business
Table 9. Amgen Herceptin Biosimilar Total Revenue (USD Million) (2018-2019)
Table 10. Amgen SWOT Analysis
Table 11. Amgen Herceptin Biosimilar Product and Services
Table 12. Amgen Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Mylan Basic Information, Manufacturing Base and Competitors
Table 14. Mylan Herceptin Biosimilar Major Business
Table 15. Mylan Herceptin Biosimilar Total Revenue (USD Million) (2018-2019)
Table 16. Mylan SWOT Analysis
Table 17. Mylan Herceptin Biosimilar Product and Services
Table 18. Mylan Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Celltrion Basic Information, Manufacturing Base and Competitors
Table 20. Celltrion Herceptin Biosimilar Major Business
Table 21. Celltrion Herceptin Biosimilar Total Revenue (USD Million) (2018-2019)
Table 22. Celltrion SWOT Analysis
Table 23. Celltrion Herceptin Biosimilar Product and Services
Table 24. Celltrion Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. AryoGen Biopharma Basic Information, Manufacturing Base and Competitors
Table 26. AryoGen Biopharma Herceptin Biosimilar Major Business
Table 27. AryoGen Biopharma Herceptin Biosimilar Total Revenue (USD Million) (2018-2019)
Table 28. AryoGen Biopharma SWOT Analysis
Table 29. AryoGen Biopharma Herceptin Biosimilar Product and Services
Table 30. AryoGen Biopharma Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Mabion Basic Information, Manufacturing Base and Competitors
Table 32. Mabion Herceptin Biosimilar Major Business
Table 33. Mabion Herceptin Biosimilar Total Revenue (USD Million) (2018-2019)
Table 34. Mabion SWOT Analysis
Table 35. Mabion Herceptin Biosimilar Product and Services
Table 36. Mabion Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Biocon Basic Information, Manufacturing Base and Competitors
Table 38. Biocon Herceptin Biosimilar Major Business
Table 39. Biocon Herceptin Biosimilar Total Revenue (USD Million) (2018-2019)
Table 40. Biocon SWOT Analysis
Table 41. Biocon Herceptin Biosimilar Product and Services
Table 42. Biocon Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. The Instituto Vital Brazil Basic Information, Manufacturing Base and Competitors
Table 44. The Instituto Vital Brazil Herceptin Biosimilar Major Business
Table 45. The Instituto Vital Brazil Herceptin Biosimilar Total Revenue (USD Million) (2018-2019)
Table 46. The Instituto Vital Brazil SWOT Analysis
Table 47. The Instituto Vital Brazil Herceptin Biosimilar Product and Services
Table 48. The Instituto Vital Brazil Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Genor Biopharma Basic Information, Manufacturing Base and Competitors
Table 50. Genor Biopharma Herceptin Biosimilar Major Business
Table 51. Genor Biopharma Herceptin Biosimilar Total Revenue (USD Million) (2018-2019)
Table 52. Genor Biopharma SWOT Analysis
Table 53. Genor Biopharma Herceptin Biosimilar Product and Services
Table 54. Genor Biopharma Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Gedeon Richter Basic Information, Manufacturing Base and Competitors
Table 56. Gedeon Richter Herceptin Biosimilar Major Business
Table 57. Gedeon Richter Herceptin Biosimilar Total Revenue (USD Million) (2018-2019)
Table 58. Gedeon Richter SWOT Analysis
Table 59. Gedeon Richter Herceptin Biosimilar Product and Services
Table 60. Gedeon Richter Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Roche Basic Information, Manufacturing Base and Competitors
Table 62. Roche Herceptin Biosimilar Major Business
Table 63. Roche Herceptin Biosimilar Total Revenue (USD Million) (2018-2019)
Table 64. Roche SWOT Analysis
Table 65. Roche Herceptin Biosimilar Product and Services
Table 66. Roche Herceptin Biosimilar Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Herceptin Biosimilar Sales by Manufacturer (2018-2019) (K Units)
Table 68. Global Herceptin Biosimilar Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Herceptin Biosimilar Sales by Regions (2015-2020) (K Units)
Table 70. Global Herceptin Biosimilar Sales Market Share by Regions (2015-2020)
Table 71. Global Herceptin Biosimilar Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Herceptin Biosimilar Sales by Countries (2015-2020) (K Units)
Table 73. North America Herceptin Biosimilar Sales Market Share by Countries (2015-2020)
Table 74. North America Herceptin Biosimilar Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Herceptin Biosimilar Revenue Market Share by Countries (2015-2020)
Table 76. Europe Herceptin Biosimilar Sales by Countries (2015-2020) (K Units)
Table 77. Europe Herceptin Biosimilar Sales Market Share by Countries (2015-2020)
Table 78. Europe Herceptin Biosimilar Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Herceptin Biosimilar Sales by Regions (2015-2020) (K Units)
Table 80. Asia-Pacific Herceptin Biosimilar Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Herceptin Biosimilar Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Herceptin Biosimilar Sales by Countries (2015-2020) (K Units)
Table 83. South America Herceptin Biosimilar Sales Market Share by Countries (2015-2020)
Table 84. South America Herceptin Biosimilar Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Herceptin Biosimilar Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Herceptin Biosimilar Sales by Countries (2015-2020) (K Units)
Table 87. Middle East & Africa Herceptin Biosimilar Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Herceptin Biosimilar Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Herceptin Biosimilar Revenue Market Share by Countries (2015-2020)
Table 90. Global Herceptin Biosimilar Sales by Type (2015-2020) (K Units)
Table 91. Global Herceptin Biosimilar Sales Share by Type (2015-2020)
Table 92. Global Herceptin Biosimilar Revenue by Type (2015-2020) (USD Million)
Table 93. Global Herceptin Biosimilar Revenue Share by Type (2015-2020)
Table 94. Global Herceptin Biosimilar Sales by Application (2015-2020) (K Units)
Table 95. Global Herceptin Biosimilar Sales Share by Application (2015-2020)
Table 96. Global Herceptin Biosimilar Sales Forecast by Regions (2021-2025) (K Units)
Table 97. Global Herceptin Biosimilar Market Share Forecast by Regions (2021-2025)
Table 98. Global Herceptin Biosimilar Sales Forecast by Type (2021-2025) (K Units)
Table 99. Global Herceptin Biosimilar Market Share Forecast by Type (2021-2025)
Table 100. Global Herceptin Biosimilar Sales Forecast by Application (2021-2025)
Table 101. Global Herceptin Biosimilar Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Herceptin Biosimilar Picture
Figure 2. Global Sales Market Share of Herceptin Biosimilar by Type in 2019
Figure 3. Breast Cancer Picture
Figure 4. Colorectal Cancer Picture
Figure 5. Leukemia Picture
Figure 6. Lymphoma Picture
Figure 7. Other Picture
Figure 8. Herceptin Biosimilar Sales Market Share by Application in 2018
Figure 9. Hospital & Clinics Picture
Figure 10. Oncology Centers Picture
Figure 11. Other Picture
Figure 12. Global Herceptin Biosimilar Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Herceptin Biosimilar Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Herceptin Biosimilar Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Herceptin Biosimilar Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Herceptin Biosimilar Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Herceptin Biosimilar Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Herceptin Biosimilar Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Herceptin Biosimilar Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Herceptin Biosimilar Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Herceptin Biosimilar Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Herceptin Biosimilar Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Herceptin Biosimilar Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Herceptin Biosimilar Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Herceptin Biosimilar Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Herceptin Biosimilar Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Herceptin Biosimilar Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Herceptin Biosimilar Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Herceptin Biosimilar Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Herceptin Biosimilar Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Herceptin Biosimilar Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Herceptin Biosimilar Sales Market Share by Manufacturer in 2019
Figure 33. Global Herceptin Biosimilar Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Herceptin Biosimilar Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Herceptin Biosimilar Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Herceptin Biosimilar Sales and Growth Rate (2015-2020) (K Units)
Figure 38. Global Herceptin Biosimilar Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Herceptin Biosimilar Revenue Market Share by Regions (2015-2020)
Figure 40. Global Herceptin Biosimilar Revenue Market Share by Regions in 2018
Figure 41. North America Herceptin Biosimilar Sales and Growth Rate (2015-2020)
Figure 42. Europe Herceptin Biosimilar Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Herceptin Biosimilar Sales and Growth Rate (2015-2020)
Figure 44. South America Herceptin Biosimilar Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Herceptin Biosimilar Sales and Growth Rate (2015-2020)
Figure 46. North America Herceptin Biosimilar Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Herceptin Biosimilar Sales Market Share by Countries (2015-2020)
Figure 48. North America Herceptin Biosimilar Sales Market Share by Countries in 2018
Figure 49. North America Herceptin Biosimilar Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Herceptin Biosimilar Revenue Market Share by Countries in 2018
Figure 51. United States Herceptin Biosimilar Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Canada Herceptin Biosimilar Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Mexico Herceptin Biosimilar Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Europe Herceptin Biosimilar Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Herceptin Biosimilar Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Herceptin Biosimilar Revenue Market Share by Countries in 2019
Figure 57. Germany Herceptin Biosimilar Sales and Growth Rate (2015-2020) (K Units)
Figure 58. UK Herceptin Biosimilar Sales and Growth Rate (2015-2020) (K Units)
Figure 59. France Herceptin Biosimilar Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Russia Herceptin Biosimilar Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Italy Herceptin Biosimilar Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Asia-Pacific Herceptin Biosimilar Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Herceptin Biosimilar Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Herceptin Biosimilar Revenue Market Share by Regions 2019
Figure 65. China Herceptin Biosimilar Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Japan Herceptin Biosimilar Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Korea Herceptin Biosimilar Sales and Growth Rate (2015-2020) (K Units)
Figure 68. India Herceptin Biosimilar Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Southeast Asia Herceptin Biosimilar Sales and Growth Rate (2015-2020) (K Units)
Figure 70. South America Herceptin Biosimilar Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Herceptin Biosimilar Sales Market Share by Countries in 2019
Figure 72. South America Herceptin Biosimilar Revenue Market Share by Countries in 2019
Figure 73. Brazil Herceptin Biosimilar Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Argentina Herceptin Biosimilar Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Middle East and Africa Herceptin Biosimilar Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Herceptin Biosimilar Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Herceptin Biosimilar Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Herceptin Biosimilar Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Herceptin Biosimilar Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Egypt Herceptin Biosimilar Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Turkey Herceptin Biosimilar Sales and Growth Rate (2015-2020) (K Units)
Figure 82. South Africa Herceptin Biosimilar Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Global Herceptin Biosimilar Sales and Growth Rate (2021-2025) (K Units)
Figure 84. Global Herceptin Biosimilar Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Herceptin Biosimilar Market Forecast (2021-2025) (K Units)
Figure 86. Europe Sales Herceptin Biosimilar Market Forecast (2021-2025) (K Units)
Figure 87. Asia-Pacific Sales Herceptin Biosimilar Market Forecast (2021-2025) (K Units)
Figure 88. South America Sales Herceptin Biosimilar Market Forecast (2021-2025) (K Units)
Figure 89. Middle East & Africa Sales Herceptin Biosimilar Market Forecast (2021-2025) (K Units)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
バイオシミラー薬品の世界市場 2020年 Market Overview The Biosimilar Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…- インターフェロンアルファ-2aバイオシミラーの世界市場 2020年 Market Overview The Interferon Alpha-2a Biosimilar market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…
- 大腸がん分子診断の世界市場 2020年 Market Overview The global Colorectal Cancer Molecular Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Color…
- 血液がん治療の世界市場 2020年 Market Overview The global Blood Cancer Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Blood Cancer Therap…
- 乳がん診断技術の世界市場 2020年 Market Overview The global Breast Cancer Diagnostic Technologies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Breast …